Skip to main content
Erschienen in: European Radiology 7/2023

03.02.2023 | Musculoskeletal

Predictive model based on DCE-MRI and clinical features for the evaluation of pain response after stereotactic body radiotherapy in patients with spinal metastases

verfasst von: Yongye Chen, Qizheng Wang, Guangjin Zhou, Ke Liu, Siyuan Qin, Weili Zhao, Peijin Xin, Huishu Yuan, Hongqing Zhuang, Ning Lang

Erschienen in: European Radiology | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the correlation of conventional MRI, DCE-MRI and clinical features with pain response after stereotactic body radiotherapy (SBRT) in patients with spinal metastases and establish a pain response prediction model.

Methods

Patients with spinal metastases who received SBRT in our hospital from July 2018 to April 2022 consecutively were enrolled. All patients underwent conventional MRI and DCE-MRI before treatment. Pain was assessed before treatment and in the third month after treatment, and the patients were divided into pain-response and no-pain-response groups. A multivariate logistic regression model was constructed to obtain the odds ratio and 95% confidence interval (CI) for each variable. C-index was used to evaluate the model’s discrimination performance.

Results

Overall, 112 independent spinal lesions in 89 patients were included. There were 73 (65.2%) and 39 (34.8%) lesions in the pain-response and no-pain-response groups, respectively. Multivariate analysis showed that the number of treated lesions, pretreatment pain score, Karnofsky performance status score, Bilsky grade, and the DCE-MRI quantitative parameter Ktrans were independent predictors of post-SBRT pain response in patients with spinal metastases. The discrimination performance of the prediction model was good; the C index was 0.806 (95% CI: 0.721–0.891), and the corrected C-index was 0.754.

Conclusion

Some imaging and clinical features correlated with post-SBRT pain response in patients with spinal metastases. The model based on these characteristics has a good predictive value and can provide valuable information for clinical decision-making.

Key Points

• SBRT can accurately irradiate spinal metastases with ablative doses.
• Predicting the post-SBRT pain response has important clinical implications.
• The prediction models established based on clinical and MRI features have good performance.
Literatur
1.
Zurück zum Zitat Piccioli A, Maccauro G, Spinelli MS, Biagini R, Rossi B (2015) Bone metastases of unknown origin: epidemiology and principles of management. J Orthop Traumatol 16:81–86CrossRefPubMedPubMedCentral Piccioli A, Maccauro G, Spinelli MS, Biagini R, Rossi B (2015) Bone metastases of unknown origin: epidemiology and principles of management. J Orthop Traumatol 16:81–86CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Allemani C, Matsuda T, Di Carlo V et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023–1075CrossRefPubMedPubMedCentral Allemani C, Matsuda T, Di Carlo V et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023–1075CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Chow E, Harris K, Fan G, Tsao M, Sze WM (2007) Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25:1423–1436CrossRefPubMed Chow E, Harris K, Fan G, Tsao M, Sze WM (2007) Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25:1423–1436CrossRefPubMed
4.
Zurück zum Zitat Kowalchuk RO, Waters MR, Richardson KM et al (2020) Stereotactic radiosurgery for the treatment of bulky spine metastases. J Neurooncol 148:381–388CrossRefPubMed Kowalchuk RO, Waters MR, Richardson KM et al (2020) Stereotactic radiosurgery for the treatment of bulky spine metastases. J Neurooncol 148:381–388CrossRefPubMed
5.
Zurück zum Zitat Sahgal A, Myrehaug SD, Siva S et al (2021) Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Lancet Oncol 22:1023–1033CrossRefPubMed Sahgal A, Myrehaug SD, Siva S et al (2021) Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Lancet Oncol 22:1023–1033CrossRefPubMed
6.
Zurück zum Zitat Sprave T, Verma V, Förster R et al (2018) Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiother Oncol 128:274–282CrossRefPubMed Sprave T, Verma V, Förster R et al (2018) Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiother Oncol 128:274–282CrossRefPubMed
7.
Zurück zum Zitat Sasamura K, Suzuki R, Kozuka T, Yoshimura R, Yoshioka Y, Oguchi M (2020) Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study. J Radiat Res 61:929–934CrossRefPubMedPubMedCentral Sasamura K, Suzuki R, Kozuka T, Yoshimura R, Yoshioka Y, Oguchi M (2020) Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study. J Radiat Res 61:929–934CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Guckenberger M, Mantel F, Sweeney RA et al (2021) Long-term results of dose-intensified fractionated stereotactic body radiation therapy (SBRT) for painful spinal metastases. Int J Radiat Oncol Biol Phys 110:348–357CrossRefPubMed Guckenberger M, Mantel F, Sweeney RA et al (2021) Long-term results of dose-intensified fractionated stereotactic body radiation therapy (SBRT) for painful spinal metastases. Int J Radiat Oncol Biol Phys 110:348–357CrossRefPubMed
9.
Zurück zum Zitat Amdur RJ, Bennett J, Olivier K et al (2009) A prospective, phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. Am J Clin Oncol 32:515–520CrossRefPubMed Amdur RJ, Bennett J, Olivier K et al (2009) A prospective, phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. Am J Clin Oncol 32:515–520CrossRefPubMed
10.
Zurück zum Zitat Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila PA 1976) 32:193–199CrossRefPubMed Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila PA 1976) 32:193–199CrossRefPubMed
11.
Zurück zum Zitat Choi CY, Adler JR, Gibbs IC et al (2010) Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord. Int J Radiat Oncol Biol Phys 78:499–506CrossRefPubMed Choi CY, Adler JR, Gibbs IC et al (2010) Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord. Int J Radiat Oncol Biol Phys 78:499–506CrossRefPubMed
12.
Zurück zum Zitat Sheehan JP, Shaffrey CI, Schlesinger D, Williams BJ, Arlet V, Larner J (2009) Radiosurgery in the treatment of spinal metastases: tumor control, survival, and quality of life after helical tomotherapy. Neurosurgery 65:1052–1061CrossRefPubMed Sheehan JP, Shaffrey CI, Schlesinger D, Williams BJ, Arlet V, Larner J (2009) Radiosurgery in the treatment of spinal metastases: tumor control, survival, and quality of life after helical tomotherapy. Neurosurgery 65:1052–1061CrossRefPubMed
13.
Zurück zum Zitat Puvanesarajah V, Lo SL, Aygun N et al (2015) Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy. J Neurosurg Spine 23:620–629CrossRefPubMedPubMedCentral Puvanesarajah V, Lo SL, Aygun N et al (2015) Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy. J Neurosurg Spine 23:620–629CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Cox BW, Spratt DE, Lovelock M et al (2012) International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83:e597-605CrossRefPubMed Cox BW, Spratt DE, Lovelock M et al (2012) International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83:e597-605CrossRefPubMed
15.
Zurück zum Zitat Fisher CG, DiPaola CP, Ryken TC et al (2010) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila PA 1976) 35:E1221-1229CrossRefPubMed Fisher CG, DiPaola CP, Ryken TC et al (2010) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila PA 1976) 35:E1221-1229CrossRefPubMed
16.
Zurück zum Zitat Chow E, Hoskin P, Mitera G et al (2012) Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 82:1730–1737CrossRefPubMed Chow E, Hoskin P, Mitera G et al (2012) Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 82:1730–1737CrossRefPubMed
17.
Zurück zum Zitat Bilsky MH, Laufer I, Fourney DR et al (2010) Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 13:324–328CrossRefPubMed Bilsky MH, Laufer I, Fourney DR et al (2010) Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 13:324–328CrossRefPubMed
18.
Zurück zum Zitat Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed
19.
Zurück zum Zitat Zaikova O, Fosså SD, Kongsgaard U, Kvaløy S, Giercksky KE, Skjeldal S (2010) Pain after palliative radiotherapy for spine metastases. Clin Oncol (R Coll Radiol) 22:828–836CrossRefPubMed Zaikova O, Fosså SD, Kongsgaard U, Kvaløy S, Giercksky KE, Skjeldal S (2010) Pain after palliative radiotherapy for spine metastases. Clin Oncol (R Coll Radiol) 22:828–836CrossRefPubMed
20.
Zurück zum Zitat Jabbari S, Gerszten PC, Ruschin M, Larson DA, Lo SS, Sahgal A (2016) Stereotactic body radiotherapy for spinal metastases: practice guidelines, outcomes, and risks. Cancer J 22:280–289CrossRefPubMed Jabbari S, Gerszten PC, Ruschin M, Larson DA, Lo SS, Sahgal A (2016) Stereotactic body radiotherapy for spinal metastases: practice guidelines, outcomes, and risks. Cancer J 22:280–289CrossRefPubMed
21.
Zurück zum Zitat Tree AC, Khoo VS, Eeles RA et al (2013) Stereotactic body radiotherapy for oligometastases. Lancet Oncol 14:e28-37CrossRefPubMed Tree AC, Khoo VS, Eeles RA et al (2013) Stereotactic body radiotherapy for oligometastases. Lancet Oncol 14:e28-37CrossRefPubMed
22.
Zurück zum Zitat van der Velden JM, Peters M, Verlaan JJ et al (2017) Development and internal validation of a clinical risk score to predict pain response after palliative radiation therapy in patients with bone metastases. Int J Radiat Oncol Biol Phys 99:859–866CrossRefPubMed van der Velden JM, Peters M, Verlaan JJ et al (2017) Development and internal validation of a clinical risk score to predict pain response after palliative radiation therapy in patients with bone metastases. Int J Radiat Oncol Biol Phys 99:859–866CrossRefPubMed
23.
Zurück zum Zitat Wu JS, Monk G, Clark T, Robinson J, Eigl BJ, Hagen N (2006) Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study. Clin Oncol (R Coll Radiol) 18:539–544CrossRefPubMed Wu JS, Monk G, Clark T, Robinson J, Eigl BJ, Hagen N (2006) Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study. Clin Oncol (R Coll Radiol) 18:539–544CrossRefPubMed
24.
Zurück zum Zitat Habberstad R, Frøseth TCS, Aass N et al (2021) Clinical predictors for analgesic response to radiotherapy in patients with painful bone metastases. J Pain Symptom Manage 62:681–690CrossRefPubMed Habberstad R, Frøseth TCS, Aass N et al (2021) Clinical predictors for analgesic response to radiotherapy in patients with painful bone metastases. J Pain Symptom Manage 62:681–690CrossRefPubMed
25.
Zurück zum Zitat Westhoff PG, de Graeff A, Monninkhof EM et al (2015) Quality of life in relation to pain response to radiation therapy for painful bone metastases. Int J Radiat Oncol Biol Phys 93:694–701CrossRefPubMed Westhoff PG, de Graeff A, Monninkhof EM et al (2015) Quality of life in relation to pain response to radiation therapy for painful bone metastases. Int J Radiat Oncol Biol Phys 93:694–701CrossRefPubMed
26.
Zurück zum Zitat Kirou-Mauro A, Hird A, Wong J et al (2008) Is response to radiotherapy in patients related to the severity of pretreatment pain? Int J Radiat Oncol Biol Phys 71:1208–1212CrossRefPubMed Kirou-Mauro A, Hird A, Wong J et al (2008) Is response to radiotherapy in patients related to the severity of pretreatment pain? Int J Radiat Oncol Biol Phys 71:1208–1212CrossRefPubMed
27.
Zurück zum Zitat Arcangeli G, Giovinazzo G, Saracino B et al (1998) Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys 42:1119–1126CrossRefPubMed Arcangeli G, Giovinazzo G, Saracino B et al (1998) Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys 42:1119–1126CrossRefPubMed
28.
Zurück zum Zitat Luksanapruksa P, Buchowski JM, Hotchkiss W, Tongsai S, Wilartratsami S, Chotivichit A (2017) Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis. Spine J 17:689–708CrossRefPubMed Luksanapruksa P, Buchowski JM, Hotchkiss W, Tongsai S, Wilartratsami S, Chotivichit A (2017) Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis. Spine J 17:689–708CrossRefPubMed
30.
Zurück zum Zitat Liang J, Liu D, Gao P et al (2018) Diagnostic values of DCE-MRI and DSC-MRI for differentiation between high-grade and low-grade gliomas: a comprehensive meta-analysis. Acad Radiol 25:338–348CrossRefPubMed Liang J, Liu D, Gao P et al (2018) Diagnostic values of DCE-MRI and DSC-MRI for differentiation between high-grade and low-grade gliomas: a comprehensive meta-analysis. Acad Radiol 25:338–348CrossRefPubMed
31.
Zurück zum Zitat Kang SR, Kim HW, Kim HS (2020) Evaluating the relationship between dynamic contrast-enhanced MRI (DCE-MRI) parameters and pathological characteristics in breast cancer. J Magn Reson Imaging 52:1360–1373CrossRefPubMed Kang SR, Kim HW, Kim HS (2020) Evaluating the relationship between dynamic contrast-enhanced MRI (DCE-MRI) parameters and pathological characteristics in breast cancer. J Magn Reson Imaging 52:1360–1373CrossRefPubMed
32.
Zurück zum Zitat Li X, Wang Q, Dou Y et al (2020) Soft tissue sarcoma: can dynamic contrast-enhanced (DCE) MRI be used to predict the histological grade? Skeletal Radiol 49:1829–1838CrossRefPubMed Li X, Wang Q, Dou Y et al (2020) Soft tissue sarcoma: can dynamic contrast-enhanced (DCE) MRI be used to predict the histological grade? Skeletal Radiol 49:1829–1838CrossRefPubMed
33.
Zurück zum Zitat Mitera G, Probyn L, Ford M et al (2011) Correlation of computed tomography imaging features with pain response in patients with spine metastases after radiation therapy. Int J Radiat Oncol Biol Phys 81:827–830CrossRefPubMed Mitera G, Probyn L, Ford M et al (2011) Correlation of computed tomography imaging features with pain response in patients with spine metastases after radiation therapy. Int J Radiat Oncol Biol Phys 81:827–830CrossRefPubMed
34.
Zurück zum Zitat Wakabayashi K, Koide Y, Aoyama T et al (2021) A predictive model for pain response following radiotherapy for treatment of spinal metastases. Sci Rep 11:12908CrossRefPubMedPubMedCentral Wakabayashi K, Koide Y, Aoyama T et al (2021) A predictive model for pain response following radiotherapy for treatment of spinal metastases. Sci Rep 11:12908CrossRefPubMedPubMedCentral
Metadaten
Titel
Predictive model based on DCE-MRI and clinical features for the evaluation of pain response after stereotactic body radiotherapy in patients with spinal metastases
verfasst von
Yongye Chen
Qizheng Wang
Guangjin Zhou
Ke Liu
Siyuan Qin
Weili Zhao
Peijin Xin
Huishu Yuan
Hongqing Zhuang
Ning Lang
Publikationsdatum
03.02.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 7/2023
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-09437-y

Weitere Artikel der Ausgabe 7/2023

European Radiology 7/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.